» Articles » PMID: 20037594

Characterization of the Human Neutrophil Alloantigen-3a

Overview
Journal Nat Med
Date 2009 Dec 29
PMID 20037594
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Transfusion-related acute lung injury (TRALI) is a frequent cause of transfusion-associated morbidity and mortality. Severe TRALI is often due to antibodies in blood components directed against the human neutrophil alloantigen-3a (HNA-3a). We show here that the HNA-3a antigen arises from a nucleotide polymorphism in the choline transporter-like protein-2 gene (SLC44A2), with the resulting variation at amino acid position 154 determining the reactivity of the protein with HNA-3a-specific antibodies; the variant with an arginine at this position, rather than a glutamine, constitutes the HNA-3a antigen. The molecular identification of this antigen should facilitate the development of assays for blood donor screening to lower the risk of TRALI.

Citing Articles

Lack of the human choline transporter-like protein SLC44A2 causes hearing impairment and a rare red blood phenotype.

Koehl B, Vrignaud C, Mikdar M, Nair T, Yang L, Landry S EMBO Mol Med. 2023; 15(3):e16320.

PMID: 36695047 PMC: 9994479. DOI: 10.15252/emmm.202216320.


Human neutrophil antigen 3 genotype impacts neutrophil-mediated endothelial cell cytotoxicity in a two-event model of TRALI.

Chiaretti S, Burton M, Hassel P, Radenkovic F, Devikashri N, Sultana A Blood Transfus. 2022; 20(6):465-474.

PMID: 35848624 PMC: 9726621. DOI: 10.2450/2022.0013-22.


Leukocyte-Reactive Antibodies in Female Blood Donors: The Austrian Experience.

Schonbacher M, Aichinger N, Weidner L, Jungbauer C, Grabmer C, Schuha B Transfus Med Hemother. 2021; 48(2):99-108.

PMID: 33976610 PMC: 8077487. DOI: 10.1159/000509946.


Neonatal Immune Incompatibilities between Newborn and Mother.

Arneth B J Clin Med. 2020; 9(5).

PMID: 32422924 PMC: 7291300. DOI: 10.3390/jcm9051470.


Neonatal Alloimmune Neutropenia.

Porcelijn L, de Haas M Transfus Med Hemother. 2019; 45(5):311-316.

PMID: 31049048 PMC: 6489100. DOI: 10.1159/000492949.


References
1.
Chapman C, Stainsby D, Jones H, Love E, Massey E, Win N . Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2008; 49(3):440-52. DOI: 10.1111/j.1537-2995.2008.01948.x. View

2.
Vamvakas E, Blajchman M . Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009; 113(15):3406-17. DOI: 10.1182/blood-2008-10-167643. View

3.
Yasui K, Furuta R, Matsuyama N, Fukumori Y, Kimura T, Tani Y . Possible involvement of heparin-binding protein in transfusion-related acute lung injury. Transfusion. 2008; 48(5):978-87. DOI: 10.1111/j.1537-2995.2007.01632.x. View

4.
Khan S, Kelher M, Heal J, Blumberg N, Boshkov L, Phipps R . Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 2006; 108(7):2455-62. PMC: 1895564. DOI: 10.1182/blood-2006-04-017251. View

5.
Soehnlein O, Lindbom L . Neutrophil-derived azurocidin alarms the immune system. J Leukoc Biol. 2008; 85(3):344-51. DOI: 10.1189/jlb.0808495. View